The Board of Directors of Milestone Medical Inc. (WAR: MMD, “the Company", “the Issuer") today announced the appointment of Scott Kahn as Chief Financial Officer of the Company, effective May 24, 2021. Mr. Kahn will succeed Joseph D’Agostino who retired from the Company as announced on April 13, 2021.

The Board of Directors of the Company is pleased to welcome Scott Kahn to the management team. Mr. Kahn brings more than 40 years of leadership with a proven track record in corporate and finance and operations. His deep experience and strong track record as a CFO of several pharmaceutical and medical device companies will be instrumental in growing the Company and expanding the global footprint.

All information concerning new Chief Financial Officer of the Company is attached to this report.

Legal basis: Section 3.1 point 7) of the Exhibit 3 to the Alternative Trading System Rules "Current and Periodical Information in the Alternative Trading System on the NewConnect Market". przewiń, aby zobaczyć całą tabelę

Załączniki

20210514_193002_0000133456_0000129631.pdf